Valuation: Vitrolife AB

Market Cap 11.82B 1.23B 1.07B 990M 910M 1.72B 118B 1.75B 4.64B 57.75B 4.61B 4.51B 199B P/E 2026 *
25.9x
P/E 2027 * 19.7x
Enterprise Value 12.23B 1.27B 1.11B 1.02B 942M 1.78B 122B 1.82B 4.8B 59.75B 4.77B 4.67B 206B EV / Sales 2026 *
3.49x
EV / Sales 2027 * 3.08x
Free-Float
54.39%
Yield 2026 *
1.15%
Yield 2027 * 1.07%
1 day+10.97%
1 week+10.65%
Current month+8.95%
1 month+4.03%
3 months-10.74%
6 months-28.17%
Current year-30.22%
1 week 85.35
Extreme 85.35
101.9
1 month 84.85
Extreme 84.85
101.9
Current year 84.6
Extreme 84.6
139.6
1 year 84.6
Extreme 84.6
153.5
3 years 84.6
Extreme 84.6
268
5 years 84.6
Extreme 84.6
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
02-06Buy

Chief Operating Officer

6,470 0.0048%
02-06Buy

Chief Executive Officer

3,013 0.0022%
02-04Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+11.25%+10.65%-36.81%-42.58% 1.23B
-1.93%-1.12%+239.34%+328.41% 21.61B
+0.49%+0.77%-38.97%-22.63% 9.69B
-0.18%-0.98%+41.04%+20.08% 6.79B
-4.82%+3.61%+260.99%-24.31% 5.81B
+2.44%+9.01%-16.48%-28.79% 5.1B
+0.20%-2.85%-44.71% - 4.94B
+0.63%+0.49%-21.20%-24.21% 4.21B
+7.48%+20.79%+83.44%+108.39% 4.15B
+1.85%+5.15%-13.60%-40.20% 2.74B
Average +1.74%+6.38%+45.30%+30.46% 6.63B
Weighted average by Cap. +0.01%+5.91%+97.47%+112.69%

Financials

2026 *2027 *
Net sales 3.51B 364M 318M 294M 270M 512M 35.04B 520M 1.38B 17.12B 1.37B 1.34B 59.02B 3.78B 393M 343M 317M 291M 552M 37.78B 561M 1.48B 18.47B 1.47B 1.44B 63.64B
Net income 456M 47.36M 41.41M 38.2M 35.11M 66.53M 4.56B 67.67M 179M 2.23B 178M 174M 7.68B 600M 62.32M 54.48M 50.26M 46.2M 87.54M 6B 89.04M 235M 2.93B 234M 229M 10.1B
Net Debt 411M 42.68M 37.32M 34.43M 31.65M 59.96M 4.11B 60.99M 161M 2.01B 160M 157M 6.92B -181M -18.81M -16.45M -15.17M -13.95M -26.43M -1.81B -26.88M -71.07M -885M -70.65M -69.1M -3.05B
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,126
Date Price Change Volume
16/07/26 SEK 95.60 +9.51% 438,899
15/07/26 SEK 87.30 -0.91% 155,959
14/07/26 SEK 88.10 -0.06% 114,009
13/07/26 SEK 88.15 +1.32% 115,667
10/07/26 SEK 87.00 +0.69% 116,382
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
87.30SEK
Average target price
130.20SEK
Spread / Average Target
+49.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock